Contact this trialFirst, we need to learn more about you.
Interleukin 17A Inhibitor
Izokibep for Hidradenitis Suppurativa
Recruiting0 awardsPhase 2
New York, New York
This trial is testing a new drug to treat hidradenitis suppurativa, a painful skin condition. The drug is given as a shot, and the trial will test how well it works and if it has any side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.